Your browser is no longer supported. Please, upgrade your browser.
SLNO Soleno Therapeutics, Inc. daily Stock Chart
Soleno Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.62 Insider Own13.82% Shs Outstand79.59M Perf Week-5.08%
Market Cap148.83M Forward P/E- EPS next Y-0.42 Insider Trans161.70% Shs Float47.31M Perf Month-2.09%
Income-27.00M PEG- EPS next Q-0.09 Inst Own57.20% Short Float3.41% Perf Quarter-2.60%
Sales- P/S- EPS this Y-59.70% Inst Trans0.36% Short Ratio2.55 Perf Half Y-32.25%
Book/sh1.22 P/B1.53 EPS next Y-7.70% ROA-60.70% Target Price- Perf Year28.08%
Cash/sh- P/C- EPS next 5Y15.00% ROE-113.00% 52W Range1.18 - 4.39 Perf YTD-36.39%
Dividend- P/FCF- EPS past 5Y38.50% ROI- 52W High-57.18% Beta0.50
Dividend %- Quick Ratio7.50 Sales past 5Y- Gross Margin- 52W Low59.32% ATR0.15
Employees12 Current Ratio7.50 Sales Q/Q- Oper. Margin- RSI (14)44.65 Volatility3.56% 8.08%
OptionableYes Debt/Eq0.00 EPS Q/Q49.30% Profit Margin- Rel Volume0.25 Prev Close1.87
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume632.64K Price1.88
Recom1.30 SMA20-6.00% SMA50-5.58% SMA200-25.13% Volume142,655 Change0.53%
Sep-29-20Initiated Guggenheim Buy $8
Jan-10-20Initiated Craig Hallum Buy $8
Dec-23-19Initiated Oppenheimer Outperform $10
Feb-13-18Reiterated Maxim Group Buy $8 → $4
Oct-02-20 10:46AM  
Sep-30-20 02:40PM  
Sep-15-20 08:00AM  
Aug-20-20 08:35AM  
Aug-10-20 04:01PM  
Jul-27-20 10:09AM  
Jun-29-20 09:07AM  
Jun-26-20 04:01PM  
Jun-25-20 11:15PM  
Jun-24-20 08:31AM  
Jun-23-20 04:01PM  
Jun-15-20 08:42AM  
Jun-11-20 12:00PM  
Jun-09-20 07:46AM  
Jun-08-20 04:01PM  
Jun-01-20 08:37AM  
May-12-20 04:01PM  
Apr-23-20 08:00AM  
Mar-30-20 09:41AM  
Mar-11-20 08:00AM  
Mar-04-20 04:05PM  
Jan-20-20 04:37AM  
Jan-07-20 10:21AM  
Jan-06-20 08:00AM  
Dec-23-19 07:52PM  
Nov-13-19 08:00AM  
Oct-25-19 04:30PM  
Oct-23-19 09:00AM  
Oct-22-19 04:01PM  
Oct-02-19 08:00AM  
Oct-01-19 02:22PM  
Sep-24-19 08:00AM  
Sep-19-19 08:00AM  
Aug-07-19 04:05PM  
Jul-25-19 01:19PM  
Jul-15-19 09:00AM  
Jul-11-19 11:14AM  
Jul-01-19 08:39AM  
Jun-12-19 08:00AM  
May-28-19 06:07AM  
May-24-19 08:49AM  
May-13-19 08:00AM  
May-06-19 04:13PM  
Apr-29-19 08:00AM  
Apr-03-19 08:00AM  
Mar-27-19 08:46AM  
Mar-25-19 10:00AM  
Mar-20-19 07:48AM  
Mar-18-19 08:30AM  
Mar-15-19 04:05PM  
Mar-14-19 05:32PM  
Mar-11-19 04:05PM  
Dec-19-18 04:01PM  
Dec-12-18 06:47AM  
Nov-15-18 08:05AM  
Oct-08-18 08:00AM  
Oct-01-18 08:00AM  
Sep-19-18 08:00AM  
Sep-17-18 08:00AM  
Sep-06-18 08:00AM  
Sep-04-18 08:00AM  
Aug-14-18 04:05PM  
Jul-30-18 08:00AM  
Jun-04-18 08:00AM  
May-16-18 08:00AM  
May-14-18 08:00AM  
Apr-03-18 06:15PM  
Apr-02-18 08:00AM  
Mar-26-18 08:48PM  
Mar-16-18 06:14PM  
Feb-20-18 08:00AM  
Dec-12-17 08:30AM  
Dec-11-17 08:10AM  
Dec-08-17 05:43PM  
Nov-30-17 03:15PM  
Nov-22-17 08:00AM  
Nov-14-17 03:59PM  
Oct-23-17 08:00AM  
Oct-12-17 08:00AM  
Oct-11-17 08:00AM  
Oct-05-17 01:00PM  
Sep-25-17 08:00AM  
Sep-12-17 03:37PM  
Aug-24-17 11:22AM  
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sinclair AndrewDirectorJun 26Buy1.653,333,3305,499,99510,302,602Jul 06 04:03 PM
Abingworth LLP10% OwnerJun 26Buy1.653,333,3305,499,99510,302,602Jul 06 04:02 PM
SCHULER JACK W10% OwnerJun 26Buy1.657,575,75912,500,00211,368,862Jun 26 07:49 PM
SCHULER JACK W10% OwnerJun 10Buy1.97339,083666,8072,071,883Jun 12 08:32 PM
FEINBERG LARRY N10% OwnerJun 08Sale3.40150,918513,302655,000Jun 09 05:16 PM
FEINBERG LARRY N10% OwnerJun 05Sale3.3449,325164,578805,918Jun 09 05:16 PM
Vivo Ventures V, LLC10% OwnerDec 02Sale1.6234,02855,1253,633,805Dec 03 06:01 PM
Vivo Ventures V, LLC10% OwnerNov 27Sale1.532,8984,4343,667,833Nov 27 06:05 PM
Vivo Ventures V, LLC10% OwnerNov 26Sale1.5515,17123,5153,670,731Nov 27 06:05 PM
Vivo Ventures V, LLC10% OwnerNov 25Sale1.5614,77523,0493,685,902Nov 25 08:00 PM
Vivo Ventures V, LLC10% OwnerNov 22Sale1.552,6004,0303,700,677Nov 25 08:00 PM
Vivo Ventures V, LLC10% OwnerNov 21Sale1.5544,29668,6593,703,277Nov 25 08:00 PM
Vivo Ventures V, LLC10% OwnerNov 20Sale1.5540,92963,4403,747,573Nov 20 07:11 PM
Melincoff Gwen ADirectorNov 19Buy1.5410,00015,36410,000Nov 20 05:02 PM
Vivo Ventures V, LLC10% OwnerNov 19Sale1.556009303,788,502Nov 20 07:11 PM
Vivo Ventures V, LLC10% OwnerNov 18Sale1.551001553,789,102Nov 20 07:11 PM
Vivo Ventures V, LLC10% OwnerNov 15Sale1.5551,40479,6763,789,202Nov 15 06:53 PM
Vivo Ventures V, LLC10% OwnerNov 14Sale1.5531,39148,6563,840,606Nov 15 06:53 PM
Vivo Ventures V, LLC10% OwnerNov 13Sale1.5514,22922,0553,871,997Nov 15 06:53 PM
SCHULER JACK W10% OwnerOct 25Buy1.202,563,7503,076,5006,217,345Jun 26 07:27 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.